Listen time: 27m 23s

About

Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.

Visit our Heart Failure Management Hub to discover a range of educational content to facilitate the use of SGLT-2 inhibitors and other guideline directed medical therapies as foundational treatment for HF.

Articles

Clinical Data and Experience With a Novel Right Ventricular Support Device, the Impella RP

Published:

27 October 2017

Citation:

Interventional Cardiology Review 2017;12(2 Suppl 2):17.

Ventricular Unloading and Inflammation – The Role of Impella in Myocarditis

Published:

27 October 2017

Citation:

Interventional Cardiology Review 2017;12(2 Suppl 2):15-16.

Paradoxical Mechano-energetic Costs of Acute Mechanical Intra-ventricular Unloading

Published:

27 October 2017

Citation:

Interventional Cardiology Review 2017;12(2 Suppl 2):13-14.

Impella Support and Cardiac Gene Therapy for Heart Failure

Published:

27 October 2017

Citation:

Interventional Cardiology Review 2017;12(2 Suppl 2):9-10.